Seth joined Sofinnova BioEquities as an Associate in 2026. He focuses on public investments in biotech.
Prior to Sofinnova, Seth was an Equity Research Associate at Stifel Financial where he covered small- and mid-cap biotech companies across immunology & inflammation and endocrinology. Before joining Stifel Financial, Seth was Senior Consultant at Simon Kucher.
Seth received his Ph.D. in Analytical Chemistry from Georgia State University. During his doctoral studies, he was recognized with graduate awards for research, leadership, and teaching excellence. Seth also holds an M.S. in Chemistry from Illinois State University and a B.S. in Chemistry from Miami University.